Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels

Biomaterials

Volumn 29, Issue 12, 2008, Pages 1785-1795

  Rayment, Erin A ^a   Dargaville, Tim R ^a   Shooter, Gary K ^a   George, Graeme A ^a   Upton, Zee ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Biocompatibility; Hydrogel; Matrix metalloproteinase; PHEMA; Wound dressing; Wound healing

Indexed keywords

MATRIX METALLOPROTEINASE; WOUND DRESSING; WOUND HEALING;

BIOCOMPATIBILITY; DISEASE CONTROL; ENZYME ACTIVITY; PATHOLOGY;

HYDROGELS;

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; METHACRYLIC ACID DERIVATIVE; POLY(2 HYDROXYMETHACRYLATE); PROTEINASE; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CHRONIC WOUND; CONTROLLED STUDY; DEGRADATION; DEVICE; ENZYME ACTIVITY; EX VIVO STUDY; HUMAN; HUMAN TISSUE; HYDROGEL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FAMILY; ULCER; ULCER HEALING; WOUND FLUID; WOUND HEALING;

BODY FLUIDS; DIPHOSPHONATES; DRUG CARRIERS; ENZYME ACTIVATION; HUMANS; HYDROGELS; MATERIALS TESTING; MATRIX METALLOPROTEINASES; ULCER; WOUND HEALING;

EID: 39649125192     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.12.043     Document Type: Article

References (47)

1. Cullen B., Watt P.W., Lundqvist C., Silcock D., Schmidt R.J., Bogan D., et al. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. The International Journal of Biochemistry & Cell Biology 34 12 (December 2002) 1544-1556
2. Stadelmann W.K., Digenis A.G., and Tobin G.R. Physiology and healing dynamics of chronic cutaneous wounds. The American Journal of Surgery 126 Suppl. 2A (August 24, 1998) 26S-38S
3. Tarnuzzer R.W., and Schultz G.S. Biochemical analysis of acute and chronic wound environments. Wound Repair and Regeneration 4 3 (July 1996) 321-325
4. Trengove N.J., Stacey M.C., Macauley S., Bennett N., Gibson J., Burslem F., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair and Regeneration 7 (November-December 1999) 442-452
5. Wysocki A.B., Kusakabe A.O., Chang S., and Tuan T.-L. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair and Regeneration 7 3 (May 01, 1999) 154-165
6. Yager D.R., and Nwomeh B.C. The proteolytic environment of chronic wounds. Wound Repair and Regeneration 7 6 (November 01, 1999) 433-441
7. Cullen B., Smith R., McCulloch E., Silcock D., and Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair and Regeneration 10 1 (January 01, 2002) 16-25
8. Ramamurthy N.S., McClain S.A., Pirila E., Maisi P., Salo T., Kucine A.J., et al. Wound healing in aged normal and ovariectomized rats: effects of chemically modified doxycycline (CMT-8) on MMP expression and collagen synthesis. Annals New York Academy of Sciences 878 (1999) 720-723
9. Ramamurthy N.S., Kucine A.J., McClain S.A., McNamara T.F., and Golub L.M. Topically applied CMT-2 enhances wound healing in streptozotocin diabetic rat skin. Advanced Dental Research 12 (November 1998) 144-148
10. Lund L.R., Romer J., Bugge T.H., Nielsen B.S., Frandsen T.L., Degen J.L., et al. Functional overlap between two classes of matrix-degrading proteases in wound healing. European Molecular Biology Organization Journal 18 17 (September 1, 1999) 4645-4656
11. Valleala H., Hanemaaijer R., Mandelin J., Salminen A., Teronen O., Monkkonen J., et al. Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates. Life Sciences 73 19 (September 26, 2003) 2413-2420
12. Teronen O., Heikkila P., Konttinen Y.T., Laitinen M., Salo T., Hanemaaijer R., et al. MMP inhibition and downregulation by bisphosphonates. Annals New York Academy of Sciences 878 (1999) 453-465
13. Fleisch H. Bisphosphonates in bone disease: from the laboratory to the patient. 3rd ed. (1997), Parthenon Publishing Group, New York
14. Heymann D., Ory B., Gouin F., Green J.R., and Redini F. Bisphosphonates: new therapeutic agents for the treatment of bone tumors. Trends in Molecular Medicine 10 7 (July 1, 2004) 337-343
15. Vasikaran S.D. Bisphosphonates: an overview with special reference to alendronate. Annals of Clinical Biochemistry 38 (2001) 608-623
16. Heikkila P., Teronen O., Moilanen M., Konttinen Y.T., Hanemaaijer R., Laitinen M., et al. Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anti-Cancer Drugs 13 (2002) 245-254
17. Russell R.G.G., and Rogers M.J. Bisphosphonates: from the laboratory to the clinic and back again. Bone 25 1 (July 1999) 97-106
18. Suzuki M., Raab G., Moses M., Fernandez C., and Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. Journal of Biological Chemistry 272 (1997) 31730-31737
19. McQuibban G., Butler G., Gong J., Bendall L., Power C., Clark-Lewis I., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. Journal of Biological Chemistry 276 (2001) 43503-43508
20. Levi E., Fridman R., Miao H., Ma Y., Yayon A., and Vlodavsky I. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 7069-7074
21. Gearing A., Thorpe S., Miller K., Mangan M., Varley P., Dudgeon T., et al. Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin. Immunology Letters 81 (2002) 41-48
22. Balas F., Manzano M., Horcajada P., and Vallet-Regi M. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. Journal of the American Chemical Society 128 25 (2006) 8116-8117
23. Uludag H., and Yang J. Targeting systemically administered proteins to bone by bisphosphonate conjugation. Biotechnology Progress 18 3 (2002) 604-611
24. Wang D., Miller S., Sima M., Kopeckova P., and Kopecek J. Synthesis and evaluation of water-soluble polymeric bone-targeted drug delivery systems. Bioconjugate Chemistry 14 5 (2003) 853-859
25. Otera J. Transesterification. Chemical Reviews 93 4 (1993) 1449-1470
26. Gogly B., Groult N., Hornebeck W., Godeau G., and Pellat B. Collagen zymography as a sensitive and specific technique for the determination of subpicogram levels of interstitial collagenase. Analytical Biochemistry 255 2 (January 15, 1998) 211-216
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
28. Cook H., Stephens P., Davies K.J., Harding K.G., and Thomas D.W. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. Journal of Investigative Dermatology 115 2 (August 01, 2000) 225-233
29. Lerman O.Z., Galiano R.D., Armour M., Levine J.P., and Gurtner G.C. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. American Journal of Pathology 162 1 (January 1, 2003) 303-312
30. Topping G., Malda J., Dawson R., and Upton Z. Development and characterisation of human skin equivalents and their potential application as a burn wound model. Primary Intention 14 1 (February 2006) 14-21
31. Chakrabarty K.H., Dawson R.A., Harris P., Layton C., Babu M., Gould L., et al. Development of autologous human dermal-epidermal composites based on sterilized human allodermis for clinical use. British Journal of Dermatology 141 5 (1999) 811-823
32. Yager D.R., Zhang L.Y., Liang H.-X., Diegelmann R.F., and Cohen K.I. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. Journal of Investigative Dermatology 107 (June 17, 1996) 743-748
33. Wysocki A.B., Staianocoico L., and Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. Journal of Investigative Dermatology 101 1 (July, 1993) 64-68
34. Turhanen P., and Vepsalainen J. Synthesis of novel (1-alkanoyloxy-4-alkanoylaminobutylidene)-1,1-bisphosphonic acid derivatives. Beilstein Journal of Organic Chemistry 2 1 (2006) 2
35. Suzuki S., Whittaker M.R., Grondahl L., Monteiro M.J., and Wentrup-Byrne E. Synthesis of soluble phosphate polymers by RAFT and their in vitro mineralization. Biomacromolecules 7 11 (2006) 3178-3187
36. Kemp D., and Vellaccis F. Organic chemistry (1980), Worth Publishers Inc., New York pp. 368-369
37. Suzuki S., Whittaker M., Grondahl L., Monteiro M., and Wentrup-Byrne E. In vitro mineralization of soluble and cross linked phosphate polymers (2007), International Symposium of Polymeric Materials for Regenerative Medicine, Montreal, Canada
38. Zainuddin, Hill D., Whittaker A., and Chirila T. In-vitro study of the spontaneous calcification of PHEMA-based hydrogels in simulated body fluid. Journal of Materials Science: Materials in Medicine 17 12 (December 08, 2006) 1245-1254
39. Levine B., and Williams R. The role of calcium in biological systems (1982), CRC Press, Boca Raton
40. Chirila T.V., Zainuddin, Hill D.J.T., Whittaker A.K., and Kemp A. Effect of phosphate functional groups on the calcification capacity of acrylic hydrogels. Acta Biomaterialia 3 1 (January 2007) 95-102
41. Tornier C., Rosdy M., and Maibach H.I. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Toxicology in Vitro 20 4 (June 2006) 401-416
42. Lawrence J.N. Application of in vitro human skin models to dermal irritancy: a brief overview and future prospects. Toxicology in Vitro 11 3 (June 1997) 305-312
43. Ohsawa T., Maruyama I., and Senshu T. Collateral occurrence of deimination of keratins with differentiation of an immortalized newborn rat keratinocyte cell line cultured at air-liquid interface. Journal of Dermatological Science 19 1 (January 1999) 68-73
44. Winter G.D. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 193 4812 (January 20, 1962) 293-294
45. Pietschmann P., Stohlawetz P., Brosch S., Steiner G., Smolen J.S., and Peterlik M. The effect of alendronate on cytokine production, adhesion molecule expression, and transendothelial migration of human peripheral blood mononuclear cells. Calcified Tissue International 63 4 (October 05, 1998) 325-330
46. Galkowska H., Olszewsk W.L., Wojewodzka U., Mijal J., and Filipiuk E. Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers. Surgery 134 2 (2003) 213-220
47. Xue M., Campbell D., and Jackson C.J. Protein C is an autocrine growth factor for human skin keratinocytes. Journal of Biological Chemistry 282 18 (May 4, 2007) 13610-13616